13.2.5 0 6 0 6 O
Subjects 7 15 7 15 O
with 16 20 16 20 O
an 21 23 21 23 O
active 24 30 24 30 O
bleeding 31 39 31 39 B-chronic_disease
diathesis 40 49 40 49 I-chronic_disease
or 50 52 50 52 O
on 53 55 53 55 O
oral 56 60 56 60 B-treatment
anti 61 65 61 65 I-treatment
- 65 66 65 66 I-treatment
vitamin 66 73 66 73 I-treatment
K 74 75 74 75 I-treatment
medication 76 86 76 86 I-treatment
( 87 88 87 88 O
except 88 94 88 94 O
low 95 98 95 98 O
dose 99 103 99 103 O
coumadin 104 112 104 112 B-treatment
) 112 113 112 113 O

Absolute 0 8 114 122 B-clinical_variable
poly 9 13 123 127 I-clinical_variable
count 14 19 128 133 I-clinical_variable
( 20 21 134 135 I-clinical_variable
Absolute 21 29 135 143 I-clinical_variable
neutrophil 30 40 144 154 I-clinical_variable
count 41 46 155 160 I-clinical_variable
+ 47 48 161 162 I-clinical_variable
bands 49 54 163 168 I-clinical_variable
+ 55 56 169 170 I-clinical_variable
monocytes 57 66 171 180 I-clinical_variable
) 66 67 180 181 I-clinical_variable
> 68 69 182 183 O
1,000 69 74 183 188 B-lower_bound
/ 74 75 188 189 I-lower_bound
uL 75 77 189 191 I-lower_bound

Drugs 0 5 192 197 O
to 6 8 198 200 O
treat 9 14 201 206 O
symptoms 15 23 207 215 O
of 24 26 216 218 O
progeria 27 35 219 227 B-chronic_disease
are 36 39 228 231 O
permitted 40 49 232 241 O

Fasting 0 7 242 249 B-clinical_variable
LDL 8 11 250 253 I-clinical_variable
cholesterol 12 23 254 265 I-clinical_variable
within 24 30 266 272 O
1.5x 31 35 273 277 B-upper_bound
ULN 36 39 278 281 I-upper_bound
per 40 43 282 285 O
institutional 44 57 286 299 O
guidelines 58 68 300 310 O
( 69 70 311 312 O
ie 70 72 312 314 O
, 72 73 314 315 O
< 74 75 316 317 O
195 75 78 317 320 B-upper_bound
mg 79 81 321 323 I-upper_bound
/ 81 82 323 324 I-upper_bound
dL 82 84 324 326 I-upper_bound
for 85 88 327 330 O
2 89 90 331 332 B-lower_bound
- 91 92 333 334 O
18 93 95 335 337 O
years 96 101 338 343 O
of 102 104 344 346 O
age 105 108 347 350 B-age
, 108 109 350 351 O
< 110 111 352 353 O
240 111 114 353 356 B-upper_bound
mg 115 117 357 359 I-upper_bound
/ 117 118 359 360 I-upper_bound
dL 118 120 360 362 I-upper_bound
for 121 124 363 366 O
subjects 125 133 367 375 O
> 134 135 376 377 O
18 135 137 377 379 O
years 138 143 380 385 O
old 144 147 386 389 O
) 147 148 389 390 O
* 148 149 390 391 O
and 150 153 392 395 O
Fasting 154 161 396 403 B-clinical_variable
serum 162 167 404 409 I-clinical_variable
cholesterol 168 179 410 421 I-clinical_variable
< 180 181 422 423 O
300 181 184 423 426 B-upper_bound
mg 185 187 427 429 I-upper_bound
/ 187 188 429 430 I-upper_bound
dL 188 190 430 432 I-upper_bound
( 191 192 433 434 O
< 192 193 434 435 O
7.75 193 197 435 439 B-upper_bound
mmol 198 202 440 444 I-upper_bound
/ 202 203 444 445 I-upper_bound
L 203 204 445 446 I-upper_bound
) 204 205 446 447 O
* 205 206 447 448 O
and 207 210 449 452 O
Fasting 211 218 453 460 B-clinical_variable
triglycerides 219 232 461 474 I-clinical_variable
< 233 234 475 476 O
2.5 234 237 476 479 B-upper_bound
ULN 238 241 480 483 I-upper_bound
( 242 243 484 485 O
< 243 244 485 486 O
325 244 247 486 489 B-upper_bound
mg 248 250 490 492 I-upper_bound
/ 250 251 492 493 I-upper_bound
dL 251 253 493 495 I-upper_bound
for 254 257 496 499 O
ages 258 262 500 504 B-age
2 263 264 505 506 O
- 265 266 507 508 O
18 267 269 509 511 O
, 269 270 511 512 O
< 271 272 513 514 O
400 272 275 514 517 B-upper_bound
for 276 279 518 521 O
ages 280 284 522 526 O
> 285 286 527 528 O
18 286 288 528 530 O
) 288 289 530 531 O
* 289 290 531 532 O

Female 0 6 533 539 B-gender
subjects 7 15 540 548 I-gender
of 16 18 549 551 O
childbearing 19 31 552 564 O
potential 32 41 565 574 O
must 42 46 575 579 O
have 47 51 580 584 O
negative 52 60 585 593 B-pregnancy
serum 61 66 594 599 I-pregnancy
or 67 69 600 602 I-pregnancy
urine 70 75 603 608 I-pregnancy
pregnancy 76 85 609 618 I-pregnancy
test 86 90 619 623 O

Genetically 0 11 624 635 O
- 11 12 635 636 O
confirmed 12 21 636 645 O
progeria 22 30 646 654 B-chronic_disease

History 0 7 655 662 O
of 8 10 663 665 O
hepatitis 11 20 666 675 B-chronic_disease
B 21 22 676 677 I-chronic_disease
or 23 25 678 680 O
hepatitis 26 35 681 690 B-chronic_disease
C 36 37 691 692 I-chronic_disease

Impairment 0 10 693 703 O
of 11 13 704 706 O
gastrointestinal 14 30 707 723 O
function 31 39 724 732 O
or 40 42 733 735 O
gastrointestinal 43 59 736 752 B-chronic_disease
disease 60 67 753 760 I-chronic_disease
that 68 72 761 765 O
may 73 76 766 769 O
significantly 77 90 770 783 O
alter 91 96 784 789 O
the 97 100 790 793 O
absorption 101 111 794 804 O
of 112 114 805 807 O
everolimus 115 125 808 818 B-treatment
( 126 127 819 820 O
e.g. 127 131 820 824 O
, 131 132 824 825 O
ulcerative 133 143 826 836 B-chronic_disease
disease 144 151 837 844 I-chronic_disease
, 151 152 844 845 O
uncontrolled 153 165 846 858 O
nausea 166 172 859 865 O
, 172 173 865 866 O
vomiting 174 182 867 875 O
, 182 183 875 876 O
diarrhea 184 192 877 885 O
, 192 193 885 886 O
malabsorption 194 207 887 900 B-chronic_disease
syndrome 208 216 901 909 I-chronic_disease
or 217 219 910 912 O
small 220 225 913 918 B-treatment
bowel 226 231 919 924 I-treatment
resection 232 241 925 934 I-treatment
) 241 242 934 935 O
. 242 243 935 936 O
A 244 245 937 938 O
nasogastric 246 257 939 950 B-treatment
tube 258 262 951 955 I-treatment
( 263 264 956 957 I-treatment
NG 264 266 957 959 I-treatment
tube 267 271 960 964 I-treatment
) 271 272 964 965 I-treatment
or 273 275 966 968 O
gastric 276 283 969 976 B-treatment
tube 284 288 977 981 I-treatment
( 289 290 982 983 I-treatment
G 290 291 983 984 I-treatment
tube 292 296 985 989 I-treatment
) 296 297 989 990 I-treatment
is 298 300 991 993 O
allowed 301 308 994 1001 O

It 0 2 1002 1004 O
is 3 5 1005 1007 O
permissible 6 17 1008 1019 O
for 18 21 1020 1023 O
female 22 28 1024 1030 B-gender
subjects 29 37 1031 1039 I-gender
to 38 40 1040 1042 O
take 41 45 1043 1047 O
oral 46 50 1048 1052 B-contraception_consent
contraceptives 51 65 1053 1067 I-contraception_consent
or 66 68 1068 1070 I-contraception_consent
other 69 74 1071 1076 I-contraception_consent
hormonal 75 83 1077 1085 I-contraception_consent
methods 84 91 1086 1093 I-contraception_consent
while 92 97 1094 1099 O
receiving 98 107 1100 1109 O
treatment 108 117 1110 1119 B-treatment
with 118 122 1120 1124 I-treatment
everolimus 123 133 1125 1135 I-treatment

Other 0 5 1136 1141 O
concurrent 6 16 1142 1152 O
severe 17 23 1153 1159 O
and/or 24 30 1160 1166 O
uncontrolled 31 43 1167 1179 O
medical 44 51 1180 1187 O
disease 52 59 1188 1195 O
that 60 64 1196 1200 O
could 65 70 1201 1206 O
compromise 71 81 1207 1217 O
participation 82 95 1218 1231 O
in 96 98 1232 1234 O
the 99 102 1235 1238 O
study 103 108 1239 1244 O
( 109 110 1245 1246 O
i.e. 110 114 1246 1250 O
, 114 115 1250 1251 O
uncontrolled 116 128 1252 1264 O
diabetes 129 137 1265 1273 B-chronic_disease
, 137 138 1273 1274 O
uncontrolled 139 151 1275 1287 O
hypertension 152 164 1288 1300 B-chronic_disease
, 164 165 1300 1301 O
severe 166 172 1302 1308 B-chronic_disease
infection 173 182 1309 1318 I-chronic_disease
, 182 183 1318 1319 O
severe 184 190 1320 1326 B-chronic_disease
malnutrition 191 203 1327 1339 I-chronic_disease
, 203 204 1339 1340 O
chronic 205 212 1341 1348 B-chronic_disease
liver 213 218 1349 1354 I-chronic_disease
or 219 221 1355 1357 O
renal 222 227 1358 1363 B-chronic_disease
disease 228 235 1364 1371 I-chronic_disease
, 235 236 1371 1372 O
active 237 243 1373 1379 O
upper 244 249 1380 1385 B-chronic_disease
GI 250 252 1386 1388 I-chronic_disease
tract 253 258 1389 1394 I-chronic_disease
ulceration 259 269 1395 1405 I-chronic_disease
) 269 270 1405 1406 O

Other 0 5 1407 1412 O
than 6 10 1413 1417 O
the 11 14 1418 1421 O
drugs 15 20 1422 1427 O
used 21 25 1428 1432 O
in 26 28 1433 1435 O
this 29 33 1436 1440 O
protocol 34 42 1441 1449 O
, 42 43 1449 1450 O
other 44 49 1451 1456 B-treatment
drugs 50 55 1457 1462 I-treatment
targeted 56 64 1463 1471 I-treatment
to 65 67 1472 1474 I-treatment
treat 68 73 1475 1480 I-treatment
progeria 74 82 1481 1489 I-treatment
are 83 86 1490 1493 O
excluded 87 95 1494 1502 O

PT 0 2 1503 1505 B-clinical_variable
/ 2 3 1505 1506 O
PTT 3 6 1506 1509 B-clinical_variable
: 6 7 1509 1510 O
INR 8 11 1511 1514 B-clinical_variable
< 12 13 1515 1516 O
1.3 13 16 1516 1519 B-upper_bound
( 17 18 1520 1521 O
or 18 20 1521 1523 O
<3 21 23 1524 1526 O
on 24 26 1527 1529 O
anticoagulants 27 41 1530 1544 O
) 41 42 1544 1545 O

SGPT 0 4 1546 1550 B-clinical_variable
( 5 6 1551 1552 I-clinical_variable
ALT 6 9 1552 1555 I-clinical_variable
) 9 10 1555 1556 I-clinical_variable
< 11 12 1557 1558 O
and 13 16 1559 1562 O
SGOT 17 21 1563 1567 B-clinical_variable
( 22 23 1568 1569 I-clinical_variable
AST 23 26 1569 1572 I-clinical_variable
) 26 27 1572 1573 I-clinical_variable
â‰¤ 28 29 1574 1575 O
2.5x 30 34 1576 1580 B-upper_bound
normal 35 41 1581 1587 I-upper_bound
range 42 47 1588 1593 I-upper_bound
for 48 51 1594 1597 O
age 52 55 1598 1601 B-age

Sexually 0 8 1602 1610 O
active 9 15 1611 1617 O
male 16 20 1618 1622 B-gender
and 21 24 1623 1626 I-gender
female 25 31 1627 1633 I-gender
subjects 32 40 1634 1642 I-gender
of 41 43 1643 1645 O
reproductive 44 56 1646 1658 O
potential 57 66 1659 1668 O
must 67 71 1669 1673 O
agree 72 77 1674 1679 O
to 78 80 1680 1682 O
use 81 84 1683 1686 O
a 85 86 1687 1688 O
medically 87 96 1689 1698 O
accepted 97 105 1699 1707 O
form 106 110 1708 1712 O
of 111 113 1713 1715 O
birth 114 119 1716 1721 O
control 120 127 1722 1729 O
while 128 133 1730 1735 O
on 134 136 1736 1738 O
study 137 142 1739 1744 O
and 143 146 1745 1748 O
up 147 149 1749 1751 O
to 150 152 1752 1754 O
10 153 155 1755 1757 B-upper_bound
weeks 156 161 1758 1763 I-upper_bound
after 162 167 1764 1769 I-upper_bound
treatment 168 177 1770 1779 B-treatment

Signed 0 6 1780 1786 O
informed 7 15 1787 1795 O
consent 16 23 1796 1803 O
according 24 33 1804 1813 O
to 34 36 1814 1816 O
institutional 37 50 1817 1830 O
guidelines 51 61 1831 1841 O
must 62 66 1842 1846 O
be 67 69 1847 1849 O
obtained 70 78 1850 1858 O
and 79 82 1859 1862 O
subject 83 90 1863 1870 O
must 91 95 1871 1875 O
begin 96 101 1876 1881 O
therapy 102 109 1882 1889 B-treatment
within 110 116 1890 1896 O
twenty 117 123 1897 1903 B-upper_bound
- 123 124 1903 1904 I-upper_bound
eight 124 129 1904 1909 I-upper_bound
( 130 131 1910 1911 I-upper_bound
28 131 133 1911 1913 I-upper_bound
) 133 134 1913 1914 I-upper_bound
days 135 139 1915 1919 I-upper_bound

Subjects 0 8 1920 1928 O
must 9 13 1929 1933 O
not 14 17 1934 1937 B-pregnancy
be 18 20 1938 1940 I-pregnancy
pregnant 21 29 1941 1949 I-pregnancy
or 30 32 1950 1952 O
breast 33 39 1953 1959 O
- 39 40 1959 1960 O
feeding 40 47 1960 1967 O

Subjects 0 8 1968 1976 O
must 9 13 1977 1981 O
not 14 17 1982 1985 O
be 18 20 1986 1988 O
taking 21 27 1989 1995 O
medications 28 39 1996 2007 B-treatment
that 40 44 2008 2012 O
significantly 45 58 2013 2026 O
affect 59 65 2027 2033 O
the 66 69 2034 2037 O
metabolism 70 80 2038 2048 O
of 81 83 2049 2051 O
lonafarnib 84 94 2052 2062 B-treatment

Subjects 0 8 2063 2071 O
receiving 9 18 2072 2081 O
chronic 19 26 2082 2089 B-treatment
, 26 27 2089 2090 O
systemic 28 36 2091 2099 B-treatment
treatment 37 46 2100 2109 I-treatment
with 47 51 2110 2114 O
corticosteroids 52 67 2115 2130 B-treatment
or 68 70 2131 2133 O
another 71 78 2134 2141 O
immunosuppressive 79 96 2142 2159 B-treatment
agent 97 102 2160 2165 I-treatment

Subjects 0 8 2166 2174 O
who 9 12 2175 2178 O
have 13 17 2179 2183 O
any 18 21 2184 2187 O
severe 22 28 2188 2194 O
and/or 29 35 2195 2201 O
uncontrolled 36 48 2202 2214 O
medical 49 56 2215 2222 B-chronic_disease
conditions 57 67 2223 2233 I-chronic_disease
or 68 70 2234 2236 O
other 71 76 2237 2242 O
conditions 77 87 2243 2253 O
that 88 92 2254 2258 O
could 93 98 2259 2264 O
affect 99 105 2265 2271 O
their 106 111 2272 2277 O
participation 112 125 2278 2291 O
in 126 128 2292 2294 O
the 129 132 2295 2298 O
study 133 138 2299 2304 O

Subjects 0 8 2305 2313 O
who 9 12 2314 2317 O
have 13 17 2318 2322 O
had 18 21 2323 2326 O
a 22 23 2327 2328 O
major 24 29 2329 2334 B-treatment
surgery 30 37 2335 2342 I-treatment
or 38 40 2343 2345 O
significant 41 52 2346 2357 O
traumatic 53 62 2358 2367 O
injury 63 69 2368 2374 O
within 70 76 2375 2381 O
4 77 78 2382 2383 B-upper_bound
weeks 79 84 2384 2389 I-upper_bound
of 85 87 2390 2392 O
start 88 93 2393 2398 O
of 94 96 2399 2401 O
study 97 102 2402 2407 B-treatment
drug 103 107 2408 2412 I-treatment

Subjects 0 8 2413 2421 O
who 9 12 2422 2425 O
have 13 17 2426 2430 O
known 18 23 2431 2436 O
or 24 26 2437 2439 O
suspected 27 36 2440 2449 O
hypersensitivity 37 53 2450 2466 O
to 54 56 2467 2469 O
any 57 60 2470 2473 B-allergy_name
of 61 63 2474 2476 I-allergy_name
the 64 67 2477 2480 I-allergy_name
excipients 68 78 2481 2491 I-allergy_name
included 79 87 2492 2500 I-allergy_name
in 88 90 2501 2503 I-allergy_name
the 91 94 2504 2507 I-allergy_name
formulation 95 106 2508 2519 I-allergy_name
should 107 113 2520 2526 O
not 114 117 2527 2530 O
be 118 120 2531 2533 O
treated 121 128 2534 2541 O

Subjects 0 8 2542 2550 O
with 9 13 2551 2555 O
endocrine 14 23 2556 2565 B-chronic_disease
deficiencies 24 36 2566 2578 I-chronic_disease
are 37 40 2579 2582 O
allowed 41 48 2583 2590 O
to 49 51 2591 2593 O
receive 52 59 2594 2601 O
physiologic 60 71 2602 2613 O
or 72 74 2614 2616 O
stress 75 81 2617 2623 O
doses 82 87 2624 2629 O
of 88 90 2630 2632 O
steroids 91 99 2633 2641 B-treatment
if 100 102 2642 2644 O
necessary 103 112 2645 2654 O
. 112 113 2654 2655 O
Topical 114 121 2656 2663 B-treatment
or 122 124 2664 2666 O
inhaled 125 132 2667 2674 B-treatment
steroids 133 141 2675 2683 I-treatment
are 142 145 2684 2687 O
allowed 146 153 2688 2695 O

active 0 6 2696 2702 B-chronic_disease
( 7 8 2703 2704 O
acute 8 13 2704 2709 O
or 14 16 2710 2712 O
chronic 17 24 2713 2720 O
) 24 25 2720 2721 O
or 26 28 2722 2724 O
uncontrolled 29 41 2725 2737 B-chronic_disease
severe 42 48 2738 2744 I-chronic_disease
infections 49 59 2745 2755 I-chronic_disease

bilirubin 0 9 2756 2765 B-clinical_variable
â‰¤ 10 11 2766 2767 O
1.5x 12 16 2768 2772 B-upper_bound
upper 17 22 2773 2778 I-upper_bound
limit 23 28 2779 2784 I-upper_bound
of 29 31 2785 2787 I-upper_bound
normal 32 38 2788 2794 I-upper_bound
for 39 42 2795 2798 O
age 43 46 2799 2802 B-age

creatinine 0 10 2803 2813 B-clinical_variable
â‰¤ 11 12 2814 2815 O
1.5 13 16 2816 2819 B-upper_bound
times 17 22 2820 2825 I-upper_bound
upper 23 28 2826 2831 I-upper_bound
limit 29 34 2832 2837 I-upper_bound
of 35 37 2838 2840 I-upper_bound
normal 38 44 2841 2847 I-upper_bound
( 45 46 2848 2849 I-upper_bound
ULN 46 49 2849 2852 I-upper_bound
) 49 50 2852 2853 I-upper_bound
for 51 54 2854 2857 O
age 55 58 2858 2861 B-age
or 59 61 2862 2864 O
Glomerular 62 72 2865 2875 B-clinical_variable
filtration 73 83 2876 2886 I-clinical_variable
rate 84 88 2887 2891 I-clinical_variable
( 89 90 2892 2893 I-clinical_variable
GFR 90 93 2893 2896 I-clinical_variable
) 93 94 2896 2897 I-clinical_variable
> 95 96 2898 2899 O
70 96 98 2899 2901 B-lower_bound
mL 99 101 2902 2904 I-lower_bound
/ 101 102 2904 2905 I-lower_bound
min/1.73m2 102 112 2905 2915 I-lower_bound

currently 0 9 2916 2925 O
receiving 10 19 2926 2935 O
lonafarnib 20 30 2936 2946 B-treatment
under 31 36 2947 2952 O
protocol 37 45 2953 2961 O
09 46 48 2962 2964 O
- 48 49 2964 2965 O
06 49 51 2965 2967 O
- 51 52 2967 2968 O
0298 52 56 2968 2972 O

display 0 7 2973 2980 O
clinical 8 16 2981 2989 O
signs 17 22 2990 2995 O
of 23 25 2996 2998 O
progeria 26 34 2999 3007 B-chronic_disease
as 35 37 3008 3010 O
per 38 41 3011 3014 O
the 42 45 3015 3018 O
clinical 46 54 3019 3027 B-treatment
trial 55 60 3028 3033 I-treatment
team 61 65 3034 3038 O

have 0 4 3039 3043 O
not 5 8 3044 3047 O
experienced 9 20 3048 3059 O
a 21 22 3060 3061 O
grade 23 28 3062 3067 B-lower_bound
3 29 30 3068 3069 I-lower_bound
or 31 33 3070 3072 O
4 34 35 3073 3074 B-upper_bound
toxicity 36 44 3075 3083 B-clinical_variable
within 45 51 3084 3090 O
two 52 55 3091 3094 B-upper_bound
months 56 62 3095 3101 I-upper_bound
preceding 63 72 3102 3111 I-upper_bound
enrollment 73 83 3112 3122 O

have 0 4 3123 3127 O
not 5 8 3128 3131 O
recovered 9 18 3132 3141 O
from 19 23 3142 3146 O
the 24 27 3147 3150 O
side 28 32 3151 3155 O
effects 33 40 3156 3163 O
of 41 43 3164 3166 O
any 44 47 3167 3170 O
major 48 53 3171 3176 B-treatment
surgery 54 61 3177 3184 I-treatment
( 62 63 3185 3186 O
defined 63 70 3186 3193 O
as 71 73 3194 3196 O
requiring 74 83 3197 3206 O
general 84 91 3207 3214 B-treatment
anesthesia 92 102 3215 3225 I-treatment
but 103 106 3226 3229 O
excluding 107 116 3230 3239 O
a 117 118 3240 3241 O
procedure 119 128 3242 3251 O
for 129 132 3252 3255 O
insertion 133 142 3256 3265 O
of 143 145 3266 3268 O
central 146 153 3269 3276 O
venous 154 160 3277 3283 O
access 161 167 3284 3290 O
) 167 168 3290 3291 O

hemoglobin 0 10 3292 3302 B-clinical_variable
> 11 12 3303 3304 O
9 12 13 3304 3305 B-lower_bound
g 14 15 3306 3307 I-lower_bound
/ 15 16 3307 3308 I-lower_bound
dL 16 18 3308 3310 I-lower_bound

ho 0 2 3311 3313 O
may 3 6 3314 3317 O
require 7 14 3318 3325 O
major 15 20 3326 3331 B-treatment
surgery 21 28 3332 3339 I-treatment
during 29 35 3340 3346 O
the 36 39 3347 3350 O
course 40 46 3351 3357 O
of 47 49 3358 3360 O
the 50 53 3361 3364 O
study 54 59 3365 3370 O

known 0 5 3371 3376 O
history 6 13 3377 3384 O
of 14 16 3385 3387 O
Human 17 22 3388 3393 B-chronic_disease
Immunodeficiency 23 39 3394 3410 I-chronic_disease
Virus 40 45 3411 3416 I-chronic_disease
( 46 47 3417 3418 I-chronic_disease
HIV 47 50 3418 3421 I-chronic_disease
) 50 51 3421 3422 I-chronic_disease
seropositivity 52 66 3423 3437 O
or 67 69 3438 3440 O
known 70 75 3441 3446 O
immunodeficiency 76 92 3447 3463 B-chronic_disease

known 0 5 3464 3469 O
severely 6 14 3470 3478 O
impaired 15 23 3479 3487 B-chronic_disease
lung 24 28 3488 3492 I-chronic_disease
function 29 37 3493 3501 I-chronic_disease

liver 0 5 3502 3507 B-chronic_disease
disease 6 13 3508 3515 I-chronic_disease
such 14 18 3516 3520 O
as 19 21 3521 3523 O
cirrhosis 22 31 3524 3533 B-chronic_disease
, 31 32 3533 3534 O
chronic 33 40 3535 3542 B-chronic_disease
active 41 47 3543 3549 I-chronic_disease
hepatitis 48 57 3550 3559 I-chronic_disease
or 58 60 3560 3562 O
chronic 61 68 3563 3570 B-chronic_disease
persistent 69 79 3571 3581 I-chronic_disease
hepatitis 80 89 3582 3591 I-chronic_disease

no 0 2 3592 3594 O
recent 3 9 3595 3601 O
fractures 10 19 3602 3611 O
or 20 22 3612 3614 O
major 23 28 3615 3620 B-treatment
surgery 29 36 3621 3628 I-treatment
( 37 38 3629 3630 O
within 38 44 3630 3636 O
four 45 49 3637 3641 B-upper_bound
weeks 50 55 3642 3647 I-upper_bound
) 55 56 3647 3648 O

platelets 0 9 3649 3658 B-clinical_variable
> 10 11 3659 3660 O
75,000 11 17 3660 3666 B-lower_bound
/ 17 18 3666 3667 I-lower_bound
uL 18 20 3667 3669 I-lower_bound
( 21 22 3670 3671 O
transfusion 22 33 3671 3682 O
independent 34 45 3683 3694 O
) 45 46 3694 3695 O

serum 0 5 3696 3701 B-clinical_variable
albumin 6 13 3702 3709 I-clinical_variable
greater 14 21 3710 3717 O
than 22 26 3718 3722 O
or 27 29 3723 3725 O
equal 30 35 3726 3731 O
to 36 38 3732 3734 O
2 39 40 3735 3736 B-lower_bound
g 41 42 3737 3738 I-lower_bound
/ 42 43 3738 3739 I-lower_bound
dL 43 45 3739 3741 I-lower_bound

